Skip to Main Content

The leaders of the world’s wealthiest nations and several drug makers took steps to widen equitable access to Covid-19 vaccines, such as issuing voluntary licenses to expand manufacturing, increasing donations to a global distribution program, and investing in production capacity in Africa.

Specifically, the G20 leaders asked the World Health Organization and World Trade Organization to compile a report by October on obstacles to greater vaccine access. They also agreed to extend through 2022 a WHO program called Access to Covid-19 Tools Accelerator, or ACT Accelerator, which was created to develop, produce and distribute vaccines, diagnostics and therapies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!